Skip to main content

Carbidopa and Levodopa Extended-Release Tablets Shortage

Last Updated: March 27, 2020
Status: Resolved

Products Affected - Description
    • Sinemet CR extended release tablet, Merck, 25 mg/100 mg, bottle, 100 count, NDC 00006-3919-68 - discontinued
    • Sinemet CR extended release tablet, Merck, 50 mg/200 mg, bottle, 100 count, NDC 00006-3918-68 - discontinued
Reason for the Shortage
    • Accord has 50 mg/200 mg tablets available. Accord discontinued carbidopa and levodopa 25 mg/100 mg extended-release tablets.
    • Sun Pharma has carbidopa and levodopa extended-release tablets available.
    • Merck will be discontinuing Sinemet CR 50 mg/200 mg tablets around November 2019. The 25 mg/100 mg tablets will be discontinued around February 2020.
    • Mylan has carbidopa and levodopa extended-release tablets available.
Available Products
    • Carbidopa and Levodopa extended release tablet, Accord, 50 mg/200 mg, bottle, 100 count, NDC 16729-0079-01
    • Carbidopa and Levodopa extended release tablet, Accord, 50 mg/200 mg, bottle, 1000 count, NDC 16729-0079-17
    • Carbidopa and Levodopa extended release tablet, Mylan, 25 mg/100 mg, bottle, 100 count, NDC 00378-0088-01
    • Carbidopa and Levodopa extended release tablet, Mylan, 50 mg/200 mg, bottle, 100 count, NDC 00378-0094-01
    • Carbidopa and Levodopa extended release tablet, Mylan Institutional, 25 mg/100 mg, unit-dose blister pack, 100 count, NDC 51079-0978-20
    • Carbidopa and Levodopa extended release tablet, Mylan Institutional, 50 mg/200 mg, unit-dose blister pack, 100 count, NDC 51079-0923-20
    • Carbidopa and Levodopa extended release tablet, Sun Pharma, 25 mg/100 mg, 100 count, NDC 62756-0461-88
    • Carbidopa and Levodopa extended release tablet, Sun Pharma, 50 mg/200 mg, 100 count, NDC 62756-0457-88

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated March 27, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 28, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer